ID

35104

Beschrijving

LIquid BIopsies in Lung Cancer (LIBIL); ODM derived from: https://clinicaltrials.gov/show/NCT02511288

Link

https://clinicaltrials.gov/show/NCT02511288

Trefwoorden

Versies (1)
  1. 17-02-19 17-02-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

17 februari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

Engels

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 Formulieren  
Criteria
Beschrijving

Criteria

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
Beschrijving

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C0332291
UMLS CUI [2,2]
C0026882
UMLS CUI [2,3]
C0449438
inclusion at the time of diagnostic or at relapse
Beschrijving

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Beschrijving

Neoplasm Biopsy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Beschrijving

Therapeutic procedure Before Liquid Biopsy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
cohort 2 inclusion criteria
Beschrijving

Cohort Number | Inclusion criteria

Datatype

boolean

Alias
UMLS CUI [1,1]
C0599755
UMLS CUI [1,2]
C0237753
UMLS CUI [2]
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
Beschrijving

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C1704257
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C3266992
UMLS CUI [4]
C1511021
UMLS CUI [5]
C3273087
UMLS CUI [6]
C4329227
UMLS CUI [7]
C4331215
UMLS CUI [8]
C1711106
inclusion at the time of diagnostic or at relapse
Beschrijving

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Beschrijving

Neoplasm Biopsy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Beschrijving

Therapeutic procedure Before Liquid Biopsy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
Terug naar het begin van de pagina

Similar models

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0332291 (UMLS CUI [2,1])
C0026882 (UMLS CUI [2,2])
C0449438 (UMLS CUI [2,3])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Cohort Number | Inclusion criteria
Item
cohort 2 inclusion criteria
boolean
C0599755 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1512693 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C1704257 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C3266992 (UMLS CUI [3])
C1511021 (UMLS CUI [4])
C3273087 (UMLS CUI [5])
C4329227 (UMLS CUI [6])
C4331215 (UMLS CUI [7])
C1711106 (UMLS CUI [8])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial